Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Gabriele

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|September 8, 2016
New derivatives of the antimalarial drug Pyrimethamine in the control of melanoma tumor growth: an in vitro and in vivo studyChiara Tommasino, Lucrezia Gambardella, Maria Buoncervello, et al.
Journal of Personalized Medicine|May 28, 2022
Molecular Analysis in a Glioblastoma Cohort-Results of a Prospective AnalysisLiverana Lauretti, Tonia Cenci, Nicola Montano, et al.
Oncotarget|November 5, 2017
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancerSara Santagata, Maria Napolitano, Crescenzo D'Alterio, et al.
Frontiers in Immunology|September 4, 2018
The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid ArthritisMaria Luisa Dupuis, Fabrizio Conti, Angela Maselli, et al.
Scientific Reports|May 18, 2026
Nanoplastics impair antitumor NK and CD8⁺ T cell cytotoxicity and antiviral B cell antibody responses to SARS-CoV-2Stefano Maria Santini, Francesca Spadaro, Agostina Pietrantoni, et al.
International Journal of Cancer|June 9, 2023
Reversing vemurafenib-resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effectsAlessandra Fragale, Emilia Stellacci, Giulia Romagnoli, et al.
Cancer Immunology Research|June 16, 2017
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic CellsAlessandra Fragale, Giulia Romagnoli, Valerio Licursi, et al.
Microorganisms|February 25, 2022
Distribution of <i>Interferon Lambda 4</i> Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19Leonardo Sorrentino, Valentina Silvestri, Giuseppe Oliveto, et al.
Nanoscale|March 18, 2016
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasisCaterina Ieranò, Luigi Portella, Sara Lusa, et al.
Cells|July 24, 2019
Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast CancerAngela Maselli, Stefania Parlato, Rossella Puglisi, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Experimental & Clinical Cancer Research : CR|September 8, 2016
New derivatives of the antimalarial drug Pyrimethamine in the control of melanoma tumor growth: an in vitro and in vivo studyChiara Tommasino, Lucrezia Gambardella, Maria Buoncervello, et al.
Journal of Personalized Medicine|May 28, 2022
Molecular Analysis in a Glioblastoma Cohort-Results of a Prospective AnalysisLiverana Lauretti, Tonia Cenci, Nicola Montano, et al.
Oncotarget|November 5, 2017
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancerSara Santagata, Maria Napolitano, Crescenzo D'Alterio, et al.
Frontiers in Immunology|September 4, 2018
The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid ArthritisMaria Luisa Dupuis, Fabrizio Conti, Angela Maselli, et al.
Scientific Reports|May 18, 2026
Nanoplastics impair antitumor NK and CD8⁺ T cell cytotoxicity and antiviral B cell antibody responses to SARS-CoV-2Stefano Maria Santini, Francesca Spadaro, Agostina Pietrantoni, et al.
International Journal of Cancer|June 9, 2023
Reversing vemurafenib-resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effectsAlessandra Fragale, Emilia Stellacci, Giulia Romagnoli, et al.
Cancer Immunology Research|June 16, 2017
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic CellsAlessandra Fragale, Giulia Romagnoli, Valerio Licursi, et al.
Microorganisms|February 25, 2022
Distribution of <i>Interferon Lambda 4</i> Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19Leonardo Sorrentino, Valentina Silvestri, Giuseppe Oliveto, et al.
Nanoscale|March 18, 2016
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasisCaterina Ieranò, Luigi Portella, Sara Lusa, et al.
Cells|July 24, 2019
Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast CancerAngela Maselli, Stefania Parlato, Rossella Puglisi, et al.
Pageof 6